Additionally, in the BM vascular microenvironment of AML, inhibiting the secretion of IL-4 by ECs promotes megakaryocyte proliferation, improves platelet count, and enhances the effectiveness of chemotherapy (Gao et al., 2019). Here, IL4 is linked to acute myeloid leukemia.